HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful catheter ablation of epicardial ventricular tachycardia worsened by cardiac resynchronization therapy.

Abstract
Soon after an upgrade from a single-chamber implantable cardioverter-defibrillator (ICD) to cardiac resynchronization therapy (CRT) with an ICD, a 64-year-old man with non-ischaemic cardiomyopathy began to have increasingly frequent ICD shocks for slow ventricular tachycardia (VT). At electrophysiological study, no clinical VT was induced by endocardial right ventricular pacing, but was easily induced by epicardial left ventricular (LV) pacing via a subxiphoid pericardial approach. The VT was successfully ablated on the LV epicardial surface. This case suggests that epicardial catheter ablation may be an alternative for managing CRT-induced proarrhythmias without the inactivation of LV pacing.
AuthorsTakumi Yamada, Paul B Tabereaux, H Thomas McElderry, Harish Doppalapudi, Andrew E Epstein, Vance J Plumb, G Neal Kay
JournalEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (Europace) Vol. 12 Issue 3 Pg. 437-40 (Mar 2010) ISSN: 1532-2092 [Electronic] England
PMID20019012 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Cardiac Pacing, Artificial (adverse effects)
  • Cardiomyopathies (complications, diagnostic imaging, therapy)
  • Catheter Ablation
  • Defibrillators, Implantable
  • Electrocardiography
  • Fluoroscopy
  • Humans
  • Male
  • Middle Aged
  • Pericardium
  • Tachycardia, Ventricular (diagnostic imaging, etiology, surgery)
  • Ventricular Dysfunction, Left (complications, diagnostic imaging, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: